glp 1 drugs and kidney function GLP-1 receptor agonists in patients with chronic disease either overweight or obesity GLP-1 receptor agonists are increasingly

It should be noted that some case reports did not include complete clinical, treatment, and genetic data of patients

Handling should be carried out only by qualified individuals using suitable laboratory procedures and appropriate research handling standards

Contributors: Survey translators

In a randomized controlled trial (RCT), 60 overweight PCOS patients were treated with 250 mg of carnitine supplements for 12 weeks, while the control group received a placebo (110)

L-Acetylcarnitine: a proposed therapeutic agent for painful peripheral neuropathies

A survey of the haematological, nutritional and biochemical state of the rural elderly with particular reference to vitamin C